Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track LNAI with free AI briefings, catalyst countdowns, and dilution alerts.

LNAI · Lunai Bioworks Inc.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

Deregistered. Lunai Bioworks ended its SEC registration on Nov 12, 2026 (Form 15-12G) and no longer files reports. The data below may be out of date. Read the filing
$1.7M Cash on Hand
3.6mo Cash Runway
14.8% Short Interest
Follow LNAI by email Get an email when LNAI reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about LNAI, unsubscribe in one click. Privacy

📄 Latest SEC Filings in Plain English

Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.

💰 Cash Runway & Dilution Risk

LNAI holds $1.7M in cash and short-term investments (as of Jun 30, 2026) and burns about $1.4M/quarter from operations, an estimated runway of 3.6 months at that rate (BioRadar estimate, not company guidance).

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when LNAI files for a raise →

Get the full LNAI picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for LNAI and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.